Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Akums Drugs & Pharmaceuticals Ltd
Registered Office: 304 Mohan Place LSC Saraswati,Vihar , Delhi - 110034 , Delhi , India.
Phone : +91 11 6904 1000   Fax:
Email :  cs@akums.net  
Website :  www.akums.in
Initial public offer of 27,368,151* equity shares of face value of 2 each ("Equity Shares") of Akums Drugs and Pharmaceuticals Limited ("Company" or "Issuer") for cash at a price of 679^ per equity share (including a share premium of 677 per equity share) ("Offer Price") aggregating to 1856.74 crores*^ comprising a fresh issue of 10,037,716* equity shares aggregating to 680.00*^ crores by the company ("Fresh Issue") and an offer for sale of 17,330,435 equity shares aggregating to 1176.74 crores* ("Offered Shares") by the selling shareholders, comprising of 1,512,000 equity shares aggregating to 102.67 crores* by Sanjeev Jain, 1,512,000 equity shares aggregating to 102.67 crores* by Sandeep Jain (together the "Promoter Selling Shareholders") and 14,306,435 equity shares aggregating to 971.41 crores* by Ruby QC Investment Holdings Pte. Ltd. (The "Investor Selling Shareholder") (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the "Selling Shareholders") ("Offer for Sale", together with the fresh issue, the "Offer"). This offer includes a reservation of 243,902* equity shares aggregating to 15.00 crores*^ for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constituted 17.39% and 17.23% of its post-offer paid-up equity share capital, respectively. The face value of equity shares is 2 each. The offer price is 339.50 times the face value of the equity shares. *Subject to finalization of basis of allotment ^After employee discount.

Issue Money Payable On
Opens On Closes On Application Allotment
30-Jul-24 01-Aug-24 Rs679.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :22  Further Multiples of :22

  RsCr Lead Managers to the Issue
Project Cost 637.37
Ambit Pvt Ltd
Project Financed through Current Offer 1856.74  
Post Issue Equity Share Capital 31.48  
Issue Price Rs679.00  
 
Projects
 Repayment/prepayment of all or certain borrowings of the company and subsidiary Pursuing inorganic growth initiatives through acquisitions
 Funding incremental working capital requirements of the company General corporate purposes
Promoted By
 Sanjeev Jain
 Sandeep Jain
 Akums Master Trust
Listing At
 BSE 
 NSE 
Registrar to the Issue
 Link Intime India Pvt Ltd